A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns.

scientific article published in March 2009

A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/BCR.0B013E31819A6369
P698PubMed publication ID19165091

P50authorAlexander RomanovQ57053153
P2093author name stringAdam J Singer
Steve A McClain
Jung S Huang
Shuan S Huang
Jean Rooney
Tom Zimmerman
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)329-334
P577publication date2009-03-01
P1433published inJournal of Burn Care and ResearchQ15765113
P1476titleA novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns
P478volume30

Reverse relations

cites work (P2860)
Q90429703Advancements in Regenerative Strategies Through the Continuum of Burn Care
Q38263916Advances in Research in Animal Models of Burn-Related Hypertrophic Scarring.
Q64070852Advances in surgical applications of growth factors for wound healing
Q35122999Anti-scarring properties of different tryptophan derivatives
Q27004417Cutaneous wound healing: recruiting developmental pathways for regeneration
Q55036249DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.
Q37028658Dual therapeutic functions of F-5 fragment in burn wounds: preventing wound progression and promoting wound healing in pigs
Q34589649Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts
Q41522817Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments
Q53192719Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts.
Q42557784Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions
Q34021948Nonsteroidal Anti-Inflammatory Drugs for Wounds: Pain Relief or Excessive Scar Formation?
Q34160824Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model.
Q42878776Salamander-derived, human-optimized nAG protein suppresses collagen synthesis and increases collagen degradation in primary human fibroblasts
Q38649653Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions
Q45896697Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis
Q92603195SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation
Q26863553Strategies Demonstrating Efficacy in Reducing Wound Contraction In Vivo
Q34011189The 800-nm diode laser irradiation induces skin collagen synthesis by stimulating TGF-β/Smad signaling pathway
Q50053282The safety and tolerability of topically delivered kynurenic acid in humans. A Phase 1 Randomized Double-Blind Clinical Trial
Q39005333The use of growth factors and other humoral agents to accelerate and enhance burn wound healing
Q54312837Topical application of ALK5 inhibitor A-83-01 reduces burn wound contraction in rats by suppressing myofibroblast population.
Q33734316Validation of a vertical progression porcine burn model

Search more.